The Legal Challenges Faced By The Pharmaceutical Industry In India

 
9783659354250: The Legal Challenges Faced By The Pharmaceutical Industry In India

Who is world's supplier for affordable medicines to the developing countries? Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good? The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer

"synopsis" may belong to another edition of this title.

About the Author:

Kamini Shanmugaiah holds a Master of Law in International Trade and Commercial Law from Oxford Brookes University, Oxford, United Kingdom. She also holds double degree in both areas of fields (business and law) such as management and law. Research interests: pharmaceutical patent, software patent, intellectual property rights :developing countries

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 65.00
US$ 50.10

Convert Currency

Shipping: US$ 7.89
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Shanmugaiah Kamini
Published by LAP Lambert Academic Publishing 2013-02-24 (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New paperback Quantity Available: > 20
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing 2013-02-24, 2013. paperback. Book Condition: New. Bookseller Inventory # 9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 50.10
Convert Currency

Add to Basket

Shipping: US$ 7.89
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Shanmugaiah, Kamini
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Quantity Available: 1
Seller:
Rating
[?]

Book Description Book Condition: New. Publisher/Verlag: LAP Lambert Academic Publishing | Who is world's supplier for affordable medicines to the developing countries? Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good? The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer | Format: Paperback | Language/Sprache: english | 52 pp. Bookseller Inventory # K9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.38
Convert Currency

Add to Basket

Shipping: US$ 3.54
From Germany to U.S.A.
Destination, Rates & Speeds

3.

Shanmugaiah Kamini
Published by LAP Lambert Academic Publishing (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2013. PAP. Book Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # IQ-9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 60.32
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

4.

Shanmugaiah Kamini
Published by LAP Lambert Academic Publishing (2016)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9783659354250_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 60.57
Convert Currency

Add to Basket

Shipping: US$ 5.09
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Shanmugaiah Kamini
Published by LAP Lambert Academic Publishing (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, 2013. PAP. Book Condition: New. New Book. Delivered from our UK warehouse in 3 to 5 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Bookseller Inventory # LQ-9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 55.93
Convert Currency

Add to Basket

Shipping: US$ 11.85
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Kamini Shanmugaiah
Published by LAP LAMBERT Academic Publishing (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Paperback Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description LAP LAMBERT Academic Publishing, 2013. Paperback. Book Condition: New. book. Bookseller Inventory # M3659354252

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 77.79
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

7.

Kamini Shanmugaiah
Published by LAP Lambert Academic Publishing Feb 2013 (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Taschenbuch Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description LAP Lambert Academic Publishing Feb 2013, 2013. Taschenbuch. Book Condition: Neu. Neuware - Who is world's supplier for affordable medicines to the developing countries Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer 52 pp. Englisch. Bookseller Inventory # 9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.80
Convert Currency

Add to Basket

Shipping: US$ 20.30
From Germany to U.S.A.
Destination, Rates & Speeds

8.

Kamini Shanmugaiah
Published by LAP Lambert Academic Publishing Feb 2013 (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Taschenbuch Quantity Available: 1
Seller:
Agrios-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description LAP Lambert Academic Publishing Feb 2013, 2013. Taschenbuch. Book Condition: Neu. Neuware - Who is world's supplier for affordable medicines to the developing countries Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer 52 pp. Englisch. Bookseller Inventory # 9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.80
Convert Currency

Add to Basket

Shipping: US$ 20.30
From Germany to U.S.A.
Destination, Rates & Speeds

9.

Kamini Shanmugaiah
Published by LAP LAMBERT Academic Publishing
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Paperback Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description LAP LAMBERT Academic Publishing. Paperback. Book Condition: New. Paperback. 52 pages. Dimensions: 8.7in. x 5.9in. x 0.1in.Who is worlds supplier for affordable medicines to the developing countries Who created exception to the normal tests of patentability requirement required under Article 27. 1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement , but whether it does more harm to the domestic pharmaceutical industry than good The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Bookseller Inventory # 9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 92.96
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

10.

Shanmugaiah Kamini
Published by LAP Lambert Academic Publishing, United States (2013)
ISBN 10: 3659354252 ISBN 13: 9783659354250
New Paperback Quantity Available: 1
Seller:
The Book Depository EURO
(London, United Kingdom)
Rating
[?]

Book Description LAP Lambert Academic Publishing, United States, 2013. Paperback. Book Condition: New. Language: English . Brand New Book. Who is world s supplier for affordable medicines to the developing countries? Who created exception to the normal tests of patentability requirement required under Article 27.1 of the TRIPS Agreement. The credit certainly goes to India for its daring move in the interpretation of Section 3(d) of Patent Amendment Act 2005. The question is no longer whether Section 3(d) is compatible with the TRIPS Agreement, but whether it does more harm to the domestic pharmaceutical industry than good? The efficacy requirement will be analysed taking into considerations the importance of second medical use. Utility patent or known as petty innovations are considered of importance to the generic pharmaceutical industry. Utiliy patents widely recognised in countries such as Malaysia under Section 17 of the Patents Act 1983. Utility patent must be taken into consideration by Indian patent system for a balanced patent system. The legal challenges faced by India to supply affordable medicines preventing evergreening of patents with the full enforcement of Section 3(d), grounds of compulsory licensing, are certainly a continuing challenge for our world leading pharmaceutical generic drug manufacturer. Bookseller Inventory # KNV9783659354250

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 89.68
Convert Currency

Add to Basket

Shipping: US$ 3.95
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book